This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Asia Bio Partnering Forum
2 days in-person. 2 days virtually.

April 26–27, 2023 | Singapore
May 4–5, 2023 | Virtual

Intract Pharma


Intract Pharma is pioneering oral biologics delivery by converting complex injectable biologic medicines into orals for chronic indications using its proprietary Soteria™ and Phloral™ delivery platforms. Our unique approach involves targeting large biologic drugs such as monoclonal antibodies directly to the ileum/colon, stabilise them against microbiome derived enzymes and enhance it’s local tissue and/or systemic exposure. Our first goal is to advance our lead oral antibody therapeutic that can provide a safer and more effective oral option for patients suffering from chronic inflammatory bowel diseases representing >$7bn market opportunity.